Cargando…
Incidental Leydig Cell Tumor in Patient with Hormone Resistant Prostate Cancer
We hereby present the case of a 55 years old patient with clinical diagnosis of high-risk prostate cancer T2bN1Mo Gleason 9 (4 + 5) treated with androgen deprivation therapy and external beam radiotherapy. Despite treatment, castration levels were not achieved and clinical progression was evidenced...
Autores principales: | Sánchez Pérez, M., Jiménez Marrero, P., Kim Lee, D., Neumann, M.P., Jorge Pérez, N., Hernández Hernández, C., Hernández Escobar, S., Marrero Domínguez, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5397599/ https://www.ncbi.nlm.nih.gov/pubmed/28443242 http://dx.doi.org/10.1016/j.eucr.2017.03.027 |
Ejemplares similares
-
Management of Leydig cell tumors of the testis-a case report
por: Genov, P.P., et al.
Publicado: (2019) -
Testicular leydig cell tumor revealed by hydrocele
por: Ben Kridis, Wala, et al.
Publicado: (2020) -
Leydig cell testicular tumors: About a case report
por: Chaker, Kays, et al.
Publicado: (2017) -
A testosterone-producing Leydig cell tumor metastasis during hormonal treatment of prostate cancer
por: Stokkel, Laura, et al.
Publicado: (2020) -
Incidental periprostatic schwannoma discovered during evaluation for prostatic adenocarcinoma
por: Dietrick, Barbara, et al.
Publicado: (2020)